Beiyou Investment has secured NT$105 million in funding for Meike Technology's physical therapy brand, Sheng Sheng You Dong, which aims to integrate AI into rehabilitation services and expand access to personalized patient care in Taiwan and beyond.

Target Company Information

Beiyou Investment has successfully secured NT$105 million in funding for its subsidiary, Meike Technology, which operates the physical therapy brand 'Sheng Sheng You Dong'. Established in December 2020, Sheng Sheng You Dong is a chain of physical therapy clinics that integrates artificial intelligence (AI) to create personalized exercise prescriptions for patients. As many patients struggle with chronic pain issues, the combination of AI-driven therapy and traditional methods, including manual and exercise therapies, can significantly aid in their recovery.

Chairman Zhang Weihong, who possesses extensive experience in pain management, has recognized the gradual nature of physical therapy. Different diagnostic and treatment stages must be documented to effectively track progress. However, existing digital tools frequently lack the proper design for cash-based medical services. By utilizing its past experience in digital transformation within the aesthetic medical field, Meike Technology has launched Sheng Sheng You Dong clinics that allow patients to manage their pain through AI tools. As of May 2024, 15 physical therapy clinics, 2 pain clinics, and 1 sports center have been established in northern Taiwan.

Industry Overview in Taiwan

The healthcare sector in Taiwan has undergone significant evolution, particularly in the realm of physical therapy and rehabilitation services. Given a considerable rise in chronic pain conditions among the population, integrating advan

View Source

Similar Deals

zwei.7 Avelios

2025

Series A Healthcare Facilities & Services (NEC) Other
Demeter Phagos

2025

Series A Bio Therapeutic Drugs Other
China Development Industrial Bank Anbogen Therapeutics

2024

Series A Proprietary & Advanced Pharmaceuticals Other
Taiwania Capital Syncell

2024

Series A Biotechnology & Medical Research (NEC) Other
1000Farmacie 1000Farmacie

2023

Series A Telemedicine Services Other
M Ventures, Debiopharm Innovation Fund Iktos

2023

Series A Proprietary & Advanced Pharmaceuticals Other

比翼生醫

invested in

梅科科技

in 2024

in a Series A deal

Disclosed details

Transaction Size: $3M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert